MBX smart money

Mbx Biosciences, INC. (MBX): 3 insider buys, 9 top funds holding it, 1 ETF change in the public filings.

Insider buys, 12 months$1.1M

Insider buys

FiledWhoRoleAmountPrice
2026-03-16Hawryluk P. KentPresident & CEO$526k$28.41
2025-10-21Hawryluk P. KentPresident & CEO$273k$13.64
2025-10-20Hoerter Steven L.Director$265k$13.25

Top 100 funds holding it

#FundChangeWeightValue
10Paradigm Biocapital Advisors LPADD +50%4.40%$221M
19Tcg Crossover Management, LLC1.08%$38M
22Braidwell LPTRIM -44%1.01%$23M
24Orbimed Advisors LLCTRIM -10%3.33%$180M
30Deep Track Capital, LPTRIM -63%0.63%$38M
31Affinity Asset Advisors, LLCTRIM -33%0.17%$3M
60Kynam Capital Management, LP3.03%$55M
76Polar Capital Holdings PLC0.26%$94M
84Soleus Capital Management, L.P.TRIM -50%0.54%$15M

ETF changes

ETFChangeValueReport
State Street(R) Spdr(R) S&p(R) Pharmaceuticals ETFADD+$600k2026-06-30
Open the live smart money map